Abstract��OBJECTIVE Emergency management is an important duty of the government and an important part of realizing the modernization of the governance system. Under the environment of information transmission more transparent and faster, emergencies have greater impact on the public and lead to social emergencies. Therefore, higher requirements for government management capabilities are put forward. To provide a reference for improving China��s drug emergency management system by combing and analyzing the experience of foreign drug emergency management.METHODS Through literature research, expert consultation and other methods, this paper focuses on the experience of US drug emergency management. RESULTS AND CONCLUSION The US drug emergency management system has outstanding characteristics such as sound laws and regulations, strong integration of organizational systems, perfect information management system, comprehensive emergency reserve system, and professionalization of management teams. It is of positive significance for promoting the accelerated construction of China��s medical emergency management system.
��ݼ. ����ҩƷӦ��������ϵ�ص㼰���ҹ�����ʾ[J]. �й�ҩѧ��־, 2019, 54(7): 592-596.
TIAN Jing. The Characteristics of American Drug Emergency Management System and Its Enlightenment to China. Chinese Pharmaceutical Journal, 2019, 54(7): 592-596.
CHE B Q, WU K C, YANG W L. On drug emergency inspection cases and countermeasures[J]. Chin Pharm Aff(�й�ҩ��),2016,30(11):1086-1090.
[2]
CHARLES W. Organizing for homeland security after katrina: is adaptive management what��s missing?[J]. Hum Syst Manage, 2008,27(1):302-318.
[3]
XU S H, HAN C F, MENG L P, et al. Dynamic structural analysis and reconstruction strategy of China��s emergency management system[J]. China Soft Sci(�й����ѧ), 2015, (7):20-28.
[4]
XIONG X L, GONG S W. Analysis on FDA��s functions in emergency preparation for medical countermeasures[J]. Chin Pharm Aff(�й�ҩ��),2015,29(1):83-88.
[5]
BIAN B Y, GUO J F. The impact of FDA amendment Act 2007 to US pharmaceutical industry in US and the enlightenment to drug safety surveillance system in China[J]. Chin J Pharmacovi(�й�ҩ�ﾯ��),2010, 7(4):221-223.
[6]
KUAI L P, CHEN S X, QIU X Y. Study on the supervision and re-evaluation approach to post-market medical products of FDA[J]. Chin Pharm Aff(�й�ҩ��), 2008, 22(11):964-968.
[7]
GEORGE R B, TU Y R, SUN P H. US FDA drug safety information communication platform and drug quality reporting system[J]. Chin J New Drugs(�й���ҩ��־),2014,23(13):1514-1520.
[8]
US. Food and Drug Administration. Enforcement reports[EB/OL]. (2014-05-14). http://www.fda.gov/Safety/Recalls /EnforcementReports/default. htm.
[9]
FDA. Drug Quality Reporting System ( DQRS)[EB /OL]. (2009-02-26). http://www. fda. gov/About FDA/Centers Offic-es/Office of Medical Products and Tobacco/CDER/ucm082071.htm.
[10]
US. Food and Drug Administration. Drug safety communications[EB /OL]. [2014-05-16]. http://www. fda. gov/Drugs/Drug Safety /ucm199082. htm.
[11]
WU T, CHU W G, LIU Z Y. The study on the construction and operation of strategic national stockpile of USA[J]. Chin Pharm Aff(�й�ҩ��),2009,23(12):1230-1233.
[12]
Strategic National Stockpile[EB/OL]. [2009-08-12]. http://www. bt. cdc. gov/stockpile/.
NEED J T, MOTHERSHEAD J L. Strategic national stockpile program:implications for military medicine[J]. Mil Med, 2006, 171(8):698-702.
[15]
YU S P, JIANG X S, WANG S J. The United States has a national strategic stockpile of emergency medical supplies for disaster relief[J]. China J Emergency Resuscitation Disaster Med(�й����ȸ������ֺ�ҽѧ��־), 2008, 3(4):228-230.
[16]
DAN H F. Equipment, supplies, and pharmaceuticals: how much might it cost to achieve basic surge capacity?[J]. Acad Emerg Med, 2006, 13(11):1232-1237.
[17]
BIAN B Y, CHANG F, SHAO R. The enlightment of FDA�� s drug safety risk management final guidelines to drug safety risk management in China[J]. Chin Pharm Aff(�й�ҩ��),2007,21(12):956-959.
2019, Vol. 54 
